AVTR vs MOH

The Advanced Deterministic Scorecard reveals significant financial weakness with a Piotroski F-Score of just 2/9, indicating poor profitability, deteriorating margins, and weak operating performance. Despite a reasonable Debt/Equity ratio and positive operating cash flow proxies, the company is unprofitable on a net basis (negative net margin and ROE), with declining revenue and earnings. Insider selling, a bearish technical trend, and a sharp multi-year price decline further reinforce deterioration in fundamentals. Although the forward P/E of 12.97 appears low, weak execution, shrinking profits, and lack of intrinsic value benchmarks suggest the market is pricing in continued challenges.

Molina Healthcare exhibits a stable Piotroski F-Score of 5/9, but this is overshadowed by a severe collapse in profitability and earnings quality. The company is currently trading at $151.00, which is significantly above its growth-based intrinsic value of $62.79 and its defensive Graham Number of $126.90. A rising Medical Care Ratio (MCR) of 91.7% and negative operating margins (-1.49%) indicate that rising healthcare costs are outpacing state reimbursement rates. With a 1-year price decline of 50% and a catastrophic YoY EPS growth of -154.5%, the stock appears to be in a fundamental downtrend.